Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Cell/Gene Tx channel feed
For some multiple myeloma patients, Carvykti cut risk of death by 45%
9 months ago
R&D
Pharma
EnGene unveils first set of pivotal data for NMIBC therapy
9 months ago
R&D
Italian gene therapy startup nabs $52M for rare genetic disease that Moderna is working on
9 months ago
Financing
Startups
Updated: Gene therapy maker bluebird bio cuts costs again, lays off staff
9 months ago
People
4DMT's gene therapy reduced need for standard-of-care injections to treat age-associated vision loss
9 months ago
R&D
Ex-Kite leaders step in at Kyverna as CEO exits after landing year's second-biggest IPO
9 months ago
People
A new startup wants to fight cancer with 'off-the-shelf' gene therapy, securing $26M seed round
10 months ago
Financing
Startups
BridgeBio ends development of gene therapy for adrenal gland disorder
10 months ago
R&D
Astellas CEO talks future beyond Xtandi as Japanese drugmaker puts roots in Boston
10 months ago
Pharma
CBER chief forecasts better global regulatory convergence around cell and gene therapies
10 months ago
FDA+
Biopharma companies, BARDA call for more clarity on FDA's new platform tech proposal
10 months ago
FDA+
Former Regenxbio leaders take rare disease gene therapies to startup with $15M
10 months ago
Financing
Startups
Gene insertion startup Tome Biosciences stops lab work as CEO shifts focus to deal talks
10 months ago
Startups
Bluebird's slow sickle cell launch forces rework of loan, putting cash runway at risk
10 months ago
Pharma
Avenge Bio, a cell therapy biotech from Rice, is closed
10 months ago
Metagenomi tinkers with pipeline after CSO departure, says Affini-T and Ionis pacts are progressing
10 months ago
Startups
R&D
CSL Behring says uptake of hemophilia B gene therapy slower than expected
11 months ago
Pharma
Legend continues Carvykti factory builds to cement CAR-T territory with J&J
11 months ago
Pharma
Manufacturing
FDA lifts hold on 4DMT's Fabry gene therapy
11 months ago
R&D
FDA+
Florida CNS gene therapy biotech shuts down
11 months ago
People
Startups
Galapagos pauses blood cancer CAR-T therapy trial due to one Parkinsonism event
11 months ago
Deals
R&D
Adaptimmune gets FDA accelerated approval for T cell receptor cell therapy in rare soft tissue cancer
11 months ago
FDA+
Vertex says about 20 patients have started sickle cell therapy, cuts two rare disease programs
11 months ago
R&D
Pharma
With $144M Series B, Outpace Bio beats funding goal for solid tumor cell therapies
11 months ago
Financing
Startups
First page
Previous page
4
5
6
7
8
9
10
Next page
Last page